Bio-Rad Laboratories, Inc. (BIO.B) stock
BIO.BNYSELaboratory Analytical InstrumentsFiscal year ends December 31Also trades as BIO
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 8/3055% above fair value
$379.50+0.00 (0.00%)
Close on Oct 29, 2026Market cap $10.18BP/E 46.2Yield –
Bio-Rad Laboratories market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Bio-Rad Laboratories's market cap was $9.50B on Oct 19, 2026, against $8.88B a year earlier. Over the last 5 years it ranged from $6.37B to $22.82B, with a median of $9.69B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $9.50B | +13.9% |
| 2025 | Dec 31, 2025 | $8.34B | -10.7% |
| 2024 | Dec 31, 2024 | $9.34B | -2.0% |
| 2023 | Dec 29, 2023 | $9.53B | -24.3% |
| 2022 | Dec 30, 2022 | $12.59B | -44.8% |
| 2021 | Dec 31, 2021 | $22.82B | +29.7% |
| 2020 | Dec 31, 2020 | $17.59B | +58.0% |
| 2019 | Dec 31, 2019 | $11.13B | +58.6% |
| 2018 | Dec 31, 2018 | $7.02B | -1.8% |
| 2017 | Dec 29, 2017 | $7.15B | +32.6% |
| 2016 | Dec 30, 2016 | $5.39B | +32.5% |
| 2015 | Dec 31, 2015 | $4.07B | +16.0% |
| 2014 | Dec 31, 2014 | $3.51B | -1.4% |
| 2013 | Dec 31, 2013 | $3.55B | +18.4% |
| 2012 | Dec 31, 2012 | $3.00B | +10.1% |
| 2011 | Dec 30, 2011 | $2.73B | -6.5% |
| 2010 | Dec 31, 2010 | $2.92B | +9.4% |
| 2009 | Dec 31, 2009 | $2.67B | – |